Mohammed Safi

机构：The University of Texas MD Anderson Cancer Center, Sana'a University, University of Toledo · ORCID：0000-0001-7928-2343

发表论文 51 篇 · 总被引 500 次 · h-index 12

代表论文

• Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions (2025 · Nature Reviews Clinical Oncology · 被引 51)
• Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients (2024 · Frontiers in Immunology · 被引 33)
• Integrated Chinese herbal medicine with Western Medicine versus Western Medicine in the effectiveness of primary hypertension treatment: A systematic review and meta-analysis of randomized controlled trials (2022 · Journal of Ethnopharmacology · 被引 33)
• Enhancers of mesenchymal stem cell stemness and therapeutic potency (2023 · Biomedicine & Pharmacotherapy · 被引 26)
• Cognitive behavioral therapy for depression in patients with heart failure: a systematic review and metanalysis of randomized control trials (2023 · Heart Failure Reviews · 被引 15)
• Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study (2022 · Cells · 被引 13)